Engineered Mammalian Cell Reporter for EDC Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting endocrine disruptor chemicals (EDCs) in environmental samples are inefficient, expensive, time-consuming, and unsuitable for large-scale sample testing due to their reliance on chemical analysis techniques, lacking high-throughput and cost-effective solutions.

Innovation Solution

The use of live mammalian cells engineered to express traceable fusion proteins that translocate from the cytoplasm to the nucleus in response to EDCs, allowing for high-throughput detection and quantification of EDCs in environmental samples, including water, soil, and air samples, using systems and kits that include fluorescent protein domains for visualization.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If chemical analysis techniques are used to detect EDCs, then measurement precision is improved, but productivity deteriorates due to low throughput and time-consuming procedures

Engineering Contradiction:
Improvedetection accuracyVSAvoidthroughput
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent replaces complex chemical analysis techniques with a biological sensing system using engineered mammalian cells that respond to EDCs through natural cellular mechanisms. The cells express fusion proteins containing EDC-responsive domains that undergo conformational changes or translocation in response to EDC binding, providing a biological substitution for mechanical/chemical analysis methods.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The invention creates simplified proxy systems (engineered cell lines with reporter genes) that copy the biological response to EDCs without requiring direct chemical analysis. The reporter systems (fluorescent proteins, luminescent genes) serve as detectable copies of the EDC-receptor interaction, enabling indirect but rapid detection that maintains precision while increasing throughput.

Inventive Principle:
Principle #26Copying

2Measurement precision

If chemical analysis techniques are used to detect EDCs, then measurement precision is improved, but loss of time worsens due to lengthy analysis procedures

Engineering Contradiction:
Improvedetection accuracyVSAvoidanalysis time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The engineered mammalian cells are pre-prepared with expressed fusion proteins and reporter systems before sample analysis. This preliminary preparation allows the cells to be ready for immediate response to EDCs upon sample addition, eliminating the need for time-consuming sample preparation and method setup required by chemical analysis techniques.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent replaces time-consuming chemical analysis procedures with rapid biological response measurements. The engineered cells provide real-time or near-real-time detection through reporter gene expression changes, fluorescent protein translocation, or luminescent signal changes that occur immediately upon EDC binding, dramatically reducing analysis time while maintaining detection precision.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Measurement precision

If chemical analysis techniques are used to detect EDCs, then measurement precision is improved, but device complexity worsens due to sophisticated equipment requirements

Engineering Contradiction:
Improvedetection accuracyVSAvoidequipment complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The invention uses disposable engineered cell lines that can be discarded after a single use or short-term culture period. These cell-based assays eliminate the need for expensive, complex, and maintenance-intensive chemical analysis equipment. The cells themselves serve as the detection device, requiring only simple incubation and reading equipment such as plate readers or basic fluorescence microscopes.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent substitutes complex chemical analysis instrumentation with simple biological assay equipment. The engineered mammalian cells perform the detection function that would otherwise require sophisticated mass spectrometers, HPLC systems, or GC-MS instruments, replacing mechanical/chemical complexity with biological functionality that can be measured with basic laboratory equipment.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

4Measurement precision

If chemical analysis techniques are used to detect EDCs, then measurement precision is improved, but cost worsens due to expensive reagents and equipment

Engineering Contradiction:
Improvedetection accuracyVSAvoidcost
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The engineered mammalian cells serve as inexpensive, disposable detection units that eliminate the need for expensive chemical reagents and equipment. The cells can be produced at low cost through standard mammalian cell culture techniques, and each assay uses a small number of cells that can be discarded after use, significantly reducing the per-test cost compared to chemical analysis methods requiring expensive consumables and instrument time.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The invention uses reporter gene copies (fluorescent proteins, luminescent enzymes) that provide detectable signals without requiring expensive chemical probes or reagents. These genetic copies serve as inexpensive alternatives to costly chemical analysis reagents, enabling repeated measurements at low cost while maintaining detection precision through the amplification properties of reporter gene expression.

Inventive Principle:
Principle #26Copying

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables sensitive, cost-effective, and high-throughput detection and quantification of EDCs, facilitating the monitoring of EDC levels in environmental samples, thereby addressing the limitations of existing detection methods.

Implementation Method 1

systems and kits that include fluorescent protein domains for visualization

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS9921211B2Methods for detecting and monitoring endocrine disrupting chemicals (EDCs)
Publication Date: 2018.03.20 THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES
  • US9921211B2 patent drawing
  • US9921211B2 patent drawing
  • US9921211B2 patent drawing

AI summary

Described herein are compositions, methods, a system, and kits for detection of endocrine disruptor chemicals (EDCs) in samples, such as samples of water including but not limited to waste water treatment plant effluent, using a live-cell fluorescence-based nuclear translocation reporter system. Upon binding of a ligand to a fluorescent-labeled reporter protein, the protein (and therefore the fluorescence) is translocated in a ligand level-dependent manner from the cytoplasm to the nucleus of live mammalian cells; this translocation is detectable as diffuse (cytoplasmic) fluorescence converting to localized, brightly fluorescent nuclei. The described kits can be used to reliably detect very low levels of EDC contamination, including in high throughput analysis systems as described.